Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-4.98M.
ENTERPRISE VALUE (EV)
$-4.98M
Bolt Biotherapeutics, Inc.
Market Cap
$6.72M
Enterprise Value (EV)
$-4.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $6.72M | $-4.98M |
| KALA BIO, Inc. (KALA)vs › | $6.77M | $6.54M |
| Aclarion, Inc. (ACON)vs › | $6.80M | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.85M | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.46M | $7.03M |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | $5.15M |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.41M | $5.93M |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.29M | $18.02M |
| Femasys Inc. (FEMY)vs › | $6.25M | $9.60M |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.21M | $4.55M |
Market Cap
$6.72M
Total Debt
$0.00
Cash
$11.70M
Enterprise Value
$-4.98M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
